A method using light to measure blood glucose levels could save diabetes patients from frequent finger pricks every day.

Abbott Diabetes Care has warned of faulty glucose readings on some of its devices, potentially linked to seven deaths and hundreds more serious injuries. Some 3 million of the company's FreeStyle ...

Certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus devices have been recalled Charlotte Phillipp is a Weekend Writer-Reporter at PEOPLE. She has been working at PEOPLE since 2024, and was previously ...

The multinational health care company Abbott has issued a sweeping recall of its defective continuous glucose monitoring sensors in more than a dozen countries over concerns of inaccurate readings ...

Patients are being warned to stop using some glucose monitors made by Abbott Diabetes Care after the company found malfunctioning sensors may be linked to hundreds of adverse events and several deaths ...

Malfunctioning glucose trackers made by Abbott Diabetes Care have been linked to more than 700 severe adverse events and seven potential deaths, the Food and Drug Administration (FDA) and Abbott said.

Abbot has issued a medical device correction for some of its glucose sensor products after identifying a manufacturing issue that can lead to falsely low glucose readings. The correction affects about ...

Abbott recalled three million glucose sensors over inaccurate low readings. FreeStyle Libre 3 and 3 Plus sensors caused 736 severe events, including seven deaths worldwide. Users should check their ...

Abbott issued a medical device correction for some of its glucose sensors after internal testing found that some sensors may provide false low glucose readings. Hundreds of adverse events and seven ...

Stress can make diabetes management even more challenging than it already is, because cortisol, the hormone your body releases in response to stress, makes blood sugar levels rise. Because diabetes ...

A comprehensive and critical evaluation of recent advances in sweat-based biochemical and physiological biomarkers for noninvasive diabetes monitoring. A novel emphasis on multimodal sensor ...

The US FDA has granted a De Novo Classification for the Biolinq Shine, a novel real-time glucose sensor for people with type 2 diabetes (T2D) not on insulin. The new classification allows the company ...